The Cost of Relapse in Schizophrenia
暂无分享,去创建一个
[1] A. Thomas,et al. Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment. , 1974, The American journal of psychiatry.
[2] C. M. Parkes,et al. The General Practitioner and the Schizophrenic Patient , 1962, British medical journal.
[3] W. Bilker,et al. Long-term course of hospitalization for schizophrenia: Part I. Risk for rehospitalization. , 1992, Schizophrenia bulletin.
[4] J. Gunderson,et al. The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. , 1990, Archives of general psychiatry.
[5] G. Hogarty,et al. Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. , 1979, Archives of general psychiatry.
[6] A. Korten,et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. , 1992, Psychological medicine. Monograph supplement.
[7] R. Crawford,et al. Controlled Trial of Depot Fluphenazine in Out-patient Schizophrenics , 1974, British Journal of Psychiatry.
[8] G. Hogarty,et al. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. , 1974, Archives of general psychiatry.
[9] W. Bilker,et al. Long-term course of hospitalization for schizophrenia: Part II. Change with passage of time. , 1992, Schizophrenia bulletin.
[10] S. Hirsch,et al. Depressive and Extrapyramidal Symptoms and Clinical Effects: A Trial of Fluphenazine versus Flupenthixol in Maintenance of Schizophrenic Out-patients , 1979, British Journal of Psychiatry.
[11] G. Hogarty,et al. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. , 1973, Archives of general psychiatry.
[12] J. Davis,et al. Comparative doses and costs of antipsychotic medication. , 1976, Archives of general psychiatry.
[13] D. A. Johnson. Further Observations on the Duration of Depot Neuroleptic Maintenance Therapy in Schizophrenia , 1979, British Journal of Psychiatry.
[14] R. Manderscheid,et al. Mental health, United States, 1990. , 1990 .
[15] G. R. Daniel,et al. Outpatient maintenance of chronic schizophrenics with long-acting fluphenazine. , 1973, British medical journal.
[16] C. Cl.. Effect of length of inpatient treatment for chronic schizophrenia. , 1982 .
[17] G. Marshall,et al. Relapse in schizophrenia: a review of the concept and its definitions , 1983, Psychological Medicine.
[18] Neuroleptic noncompliance in schizophrenia , 1989, Schizophrenia Research.
[19] G. Serban. Adjustment of Schizophrenics in the Community , 1980, Springer Netherlands.
[20] E. Gocka,et al. Prevention of recidivism of schizophrenics treated with fluphenazine enanthate. , 1975, Psychosomatics.
[21] G. Hogarty,et al. Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. , 1977, Archives of general psychiatry.
[22] S. Salit,et al. Have general hospitals become chronic care institutions for the mentally ill? , 1991, The American journal of psychiatry.
[23] I. R. Nicholson. Factors involved in failure to keep initial appointments with mental health professionals. , 1994, Hospital & community psychiatry.
[24] C. Caton. Effect of length of inpatient treatment for chronic schizophrenia. , 1982, The American journal of psychiatry.
[25] R. Wyatt,et al. Calculating the Cost of Schizophrenia , 1987 .
[26] T. Mcguire. Measuring the economic costs of schizophrenia. , 1991, Schizophrenia bulletin.
[27] G. Hogarty,et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion. , 1986, Archives of general psychiatry.
[28] M. Raskin,et al. Treatment problems leading to readmissions of schizophrenic patients. , 1968, Archives of general psychiatry.
[29] N. Freedman,et al. Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation. , 1967, Archives of general psychiatry.
[30] Werner Kissling. Compliance, quality assurance and standards for relapse prevention in schizophrenia. , 1994, Acta psychiatrica Scandinavica. Supplementum.
[31] M. Shepherd,et al. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia , 1978, Psychological Medicine.
[32] Z. Mahmood,et al. The Scottish First Episode Schizophrenia Study V. One-year Follow-up , 1988, British Journal of Psychiatry.
[33] Marcos Lr,et al. Have general hospitals become chronic care institutions for the mentally ill , 1991 .
[34] M. Greenblatt. Mental patients in transition , 1961 .
[35] J. Gunderson,et al. The cost of schizophrenia. , 1975, The American journal of psychiatry.
[36] L. Stein,et al. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. , 1980, Archives of general psychiatry.
[37] J. Affleck,et al. A FOLLOW‐UP OF SCHIZOPHRENIC PATIENTS IN EDINBURGH , 1963, Acta psychiatrica Scandinavica.
[38] S. Haberman,et al. Use of survival curves in analysis of antipsychotic relapse studies. , 1980, Advances in biochemical psychopharmacology.
[39] H. Akaike. A new look at the statistical model identification , 1974 .
[40] G. Hogarty,et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group. , 1991, Archives of general psychiatry.
[41] S. Hirsch,et al. III. Relapse Postponement or Relapse Prevention? The Implications for Long-term Outcome , 1985, British Journal of Psychiatry.
[42] S. Hirsch,et al. Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo , 1973, British medical journal.
[43] G. Klerman,et al. Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate. , 1980, Archives of general psychiatry.
[44] N. Capstick. Long‐term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients , 1980, Acta psychiatrica Scandinavica.